‘Slick’ new company eyes medical diagnostics market

Sally Lehrman

Nature, 1997, vol. 389, issue 6647, 107-107

Abstract: san francisco Incyte Pharmaceuticals, Inc. and SmithKline Beecham are to create a joint venture company called diaDexus to discover and commercialize molecular diagnostic products in a deal which brings together some of the newest technology in the area.

Date: 1997
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/38067 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:389:y:1997:i:6647:d:10.1038_38067

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/38067

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().